Ultrasensitive and High‐Resolution Protein Spatially Decoding Framework for Tumor Extracellular Vesicles
Open Access
- 20 November 2023
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (3) , e2304926
Abstract
Proteins localized on the surface or within the lumen of tumor‐derived extracellular vesicles (EVs) play distinct roles in cancer progression. However, quantifying both populations of proteins within EVs has been hampered due to the limited sensitivity of the existing protein detection methods and inefficient EV isolation techniques. In this study, the eSimoa framework, an innovative approach enabling spatial decoding of EV protein biomarkers with unmatched sensitivity and specificity is presented. Using the luminal eSimoa pipeline, the absolute concentration of luminal RAS or KRASG12D proteins is released and measured, uncovering their prevalence in pancreatic tumor‐derived EVs. The pulldown eSimoa pipeline measured absolute protein concentrations from low‐abundance EV subpopulations. The eSimoa assays detected EVs in both PBS and plasma samples, confirming their applicability across diverse clinical sample types. Overall, the eSimoa framework offers a valuable tool to (1) detect EVs at concentrations as low as 105 EV mL−1 in plasma, (2) quantify absolute EV protein concentrations as low as fM, and (3) decode the spatial distribution of EV proteins. This study highlights the potential of eSimoa in identifying disease‐specific EV protein biomarkers in clinical samples with minimal pre‐purification, thereby driving advancements in clinical translation.Keywords
Funding Information
- National Taiwan University (Sprout Research Project 112L7847)
- Ministry of Education (MOE 111V1025‐1)
- National Science and Technology Council (NSTC 111‐2628‐B‐002‐051)
This publication has 78 references indexed in Scilit:
- Standardization of sample collection, isolation and analysis methods in extracellular vesicle researchJournal of Extracellular Vesicles, 2013
- Characterization of Membrane-shed Microvesicles from Cytokine-stimulated β-Cells Using Proteomics StrategiesMolecular & Cellular Proteomics, 2012
- K-ras Mutations in the Plasma Correspond to Computed Tomographic Findings in Patients With Pancreatic CancerPancreas, 2012
- Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathwayJournal of Lipid Research, 2011
- Functional Specificity of Ras Isoforms: So Similar but So DifferentGenes & Cancer, 2011
- Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandinsJournal of Lipid Research, 2010
- Tetraspanin CD81-Regulated Cell Motility Plays a Critical Role in Intrahepatic Metastasis of Hepatocellular CarcinomaGastroenterology, 2008
- Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinomaCancer, 2007
- Detection of K- ras mutations in the plasma DNA of pancreatic cancer patientsJournal of Gastroenterology, 2004
- ApoB-100 Secretion by HepG2 Cells Is Regulated by the Rate of Triglyceride Biosynthesis but Not by Intracellular Lipid PoolsArteriosclerosis, Thrombosis, and Vascular Biology, 1996